证券代码：300432 证券简称：富临精工 公告编号：2025-069 富临精工股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大 遗漏，并承担个别和连带的法律责任。 富临精工股份有限公司 2025 年第三季度报告 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 □是 否 1 富临精工股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 | | | | | 单位：元 | | --- | --- | --- | --- | --- | | 项目 | 本报告期金额 | 年初至报告期期末金额 | 说明 | | | 非流动性资产处置损益（包 | | | | | | 括已计提资产减值准备的冲 | -1,999,860.44 | -3,081,324.39 | | | | ...

Financial Performance - Q3 2025 revenue was CNY 530,966,283.60, a decrease of 0.40% year-over-year, while year-to-date revenue reached CNY 1,641,225,658.68, an increase of 4.72%[5] - Net profit attributable to shareholders for Q3 2025 was CNY 7,870,365.85, down 19.39% year-over-year, and year-to-date net profit was CNY 32,065,297.54, a decrease of 2.81%[5] - Basic and diluted earnings per share for Q3 2025 were CNY 0.0324, reflecting a decline of 32.64% compared to the same period last year[5] - Total operating revenue for Q3 2025 reached CNY 1,641,225,658.68, an increase of 4.1% compared to CNY 1,567,262,281.01 in the same period last year[18] - Total operating costs amounted to CNY 1,616,347,986.57, up from CNY 1,549,667,061.42, reflecting a year-over-year increase of 4.3%[19] - Net profit for the period was CNY 32,065,297.54, a decrease of 2.8% from CNY 32,991,132.94 in the previous year[19] - The net profit attributable to the parent company's shareholders for the current period is CNY 32,065,297.54, a decrease from CNY 32,991,132.94 in the previous period, representing a decline of approximately 2.8%[20] - Basic and diluted earnings per share for the current period are both CNY 0.1320, down from CNY 0.1626 in the previous period, indicating a decrease of about 18.7%[20] Assets and Liabilities - Total assets as of September 30, 2025, were CNY 2,017,540,822.09, representing a 6.60% increase from the end of the previous year[5] - Current liabilities rose to CNY 427,033,250.32, up from CNY 313,759,369.09, indicating a significant increase of 36.0%[17] - The company's fixed assets increased to CNY 528,240,080.28, compared to CNY 386,001,591.21, representing a growth of 37.0%[17] - The total equity attributable to shareholders decreased to CNY 1,542,440,354.75 from CNY 1,568,923,599.54, a decline of 1.7%[17] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 79,603,529.89, a significant decrease of 1,120.19% year-to-date[5] - Cash inflow from operating activities totaled CNY 1,878,544,394.42, compared to CNY 1,743,319,775.64 in the previous period, reflecting an increase of approximately 7.8%[22] - The net cash flow from operating activities is negative at CNY -79,603,529.89, contrasting with a positive cash flow of CNY 7,802,824.12 in the previous period[22] - Cash inflow from investment activities is CNY 3,569,692,309.02, down from CNY 4,317,496,755.57 in the previous period, representing a decrease of about 17.3%[22] - The net cash flow from investment activities is CNY -874,227,634.13, compared to a positive CNY 287,437,973.65 in the previous period[22] - Cash inflow from financing activities is CNY 176,000,000.00, with a net cash flow of CNY 109,181,165.51, contrasting with a negative cash flow of CNY -147,125,471.36 in the previous period[22] - The ending cash and cash equivalents balance is CNY 162,046,620.84, down from CNY 372,558,918.61 in the previous period, indicating a decrease of approximately 56.5%[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 13,484[11] - The top three shareholders, Qiu Hanzhou, Qiu Hanyi, and Yang Guoxian, hold 19.23%, 14.11%, and 10.07% of shares respectively[11] - The total number of restricted shares at the end of the period is 115,521,000, with 6,510,000 shares released during the period[13] - The top ten shareholders collectively hold a significant portion of the company's shares, with the largest shareholder holding 46,704,000 shares[11] - The company has a repurchase account holding 3,500,608 shares, accounting for 1.44% of the total share capital[11] - The number of shares held by the top ten unrestricted shareholders includes significant holdings by Zheng Chanyu and Zheng Zhesheng, with 8,736,000 and 8,702,400 shares respectively[11] - The company has not disclosed any changes in the top ten shareholders due to securities lending or borrowing[11] - The company plans to release restricted shares for major shareholders on January 3, 2027[13] Other Financial Metrics - Accounts receivable increased by 35.45% to CNY 72,640,471.76 due to extended credit terms offered to quality customers[9] - Inventory rose by 84.08% to CNY 150,059,367.19, attributed to increased stock for timely order fulfillment[9] - The company reported a significant increase in other non-current assets, up 52,598.27% to CNY 281,517,214.00, mainly due to prepayments for land and equipment[10] - Financial expenses increased by 166.36% to CNY 1,608,668.48, primarily due to the rise in short-term credit borrowings[10] - The company experienced a 54.70% decrease in investment income, totaling CNY 5,749,549.02, due to reduced cash management funds[10] - Research and development expenses for the period were CNY 3,699,375.11, slightly up from CNY 3,602,018.05, reflecting a focus on innovation[19] - The company reported a financial expense of CNY 1,608,668.48, compared to a financial income of CNY -2,424,017.53 in the previous year, indicating a shift in financial performance[19] Accounting and Audit - The company has not undergone an audit for the third quarter financial report[24] - The company plans to implement new accounting standards starting from 2025[24]

北京百普赛斯生物科技股份有限公司 2025 年第三季度报告 证券代码：301080 证券简称：百普赛斯 公告编号：2025-067 北京百普赛斯生物科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 北京百普赛斯生物科技股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司 2025 年 1-9 月因股份支付影响当期损益的金额为 8,321,702.80 元，扣除股份支付影响后归属于母公司上市股东的 净利润为 140,748,079.80 元。 公司报告期末至季度报告披露日股本是否因发行新股、增发、配股、股权激励行权、回购等原因发生变化且影响所有者 权益金额 是 □否 | ...

Financial Performance - Q3 2025 revenue was CNY 429,711,382.89, a decrease of 47.68% year-over-year[4] - Net profit attributable to shareholders was CNY 62,930,684.98, down 70.56% compared to the same period last year[4] - Basic earnings per share decreased to CNY 0.44, a decline of 70.47% year-over-year[4] - The net profit after deducting non-recurring gains and losses was CNY 58,840,189.61, down 72.40% year-over-year[4] - Net profit for the first nine months of 2025 was 367.5 million, a decrease of 30.79% compared to the same period in 2024[10] - Operating profit decreased by 32.00% year-on-year to 421.2 million, attributed to a decline in sales revenue and increased period expenses[10] - The net profit attributable to shareholders was 368 million RMB, down 30.79% year-on-year, primarily due to the impact of increased tariffs imposed by the U.S. on China[18] - The total profit for the current period is ¥419,631,160.56, down from ¥619,089,833.96, reflecting a decline of 32.3%[33] - The operating profit decreased to ¥421,211,827.12 from ¥619,428,543.14, representing a drop of 32.0%[33] - The total comprehensive income for the current period is ¥335,913,956.38, down from ¥534,314,938.66, indicating a decrease of 37.1%[34] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,744,894,018.96, a decrease of 3.29% from the previous year[4] - The company reported a decrease in total equity attributable to shareholders of CNY 1,808,000,243.37, a decline of 7.98%[4] - Total liabilities decreased by 31.76% year-on-year in accounts payable to 245.9 million, mainly due to reduced payable for materials[10] - The company's total liabilities reached approximately 936.89 million RMB, up from 873.49 million RMB at the beginning of the period[29] - The company's equity attributable to shareholders decreased to approximately 1.81 billion RMB from 1.96 billion RMB, a decline of about 7.9%[31] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 692,996,049.48, an increase of 132.44%[4] - Cash flow from operating activities increased by 132.44% year-on-year to 693.0 million, mainly due to increased cash received from sales[12] - The company reported a 770.82% increase in cash received from investment redemption to 2.1 billion, reflecting increased financial product redemptions[12] - The company's cash flow from financing activities showed a net outflow of 357.1 million, primarily due to increased cash dividends and share repurchases[12] - The cash flow from investment activities showed a net outflow of ¥377,903,948.50, worsening from a net outflow of ¥159,420,330.45 in the previous period[36] - The cash flow from financing activities resulted in a net outflow of ¥357,124,344.36, compared to a net outflow of ¥163,795,836.88 in the previous period[38] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 8,183, indicating a stable shareholder base[14] - As of September 30, 2025, the company repurchased 1,086,080 shares, accounting for 0.75% of the total shares[15] - The total number of restricted shares at the end of the period was 10,022,197, with 1,681,425 shares released from restrictions during the period[16] - The company adjusted the repurchase price of restricted shares from 7.90 RMB to 3.50 RMB, increasing the repurchase quantity from 47,400 to 66,360 shares[20] - The company intends to repurchase shares with a budget between 80 million and 160 million RMB, having already repurchased 1,086,080 shares, accounting for 0.7467% of the total share capital[25] Operational Developments - The company has fully streamlined its production system in Vietnam, with certification testing successfully completed, leading to a gradual increase in order volume from the Vietnam factory[18] - The company plans to further promote automation upgrades and improve supply chain support at its Vietnam factory[18] - The company has increased its investment in research and development to accelerate the layout of new product categories[18] - The company is actively expanding its customer base while optimizing its product structure to enhance global delivery capabilities[18] - The company plans to grant 238,700 restricted stock units to 83 eligible participants under the 2024 restricted stock incentive plan[23] - The company issued 3,979,384 convertible bonds, with a total value of approximately 39.79 million RMB, which will be listed on the Shenzhen Stock Exchange starting November 26, 2024[24] Other Income - Non-recurring gains and losses totaled CNY 4,090,495.37 for the quarter[6] - Other income increased by 107.66% year-on-year to 13.4 million, mainly due to increased government subsidies received[10] - The company reported other income of ¥13,417,986.07, an increase from ¥6,461,396.81 in the previous period, representing a growth of 107.5%[33]

北京九强生物技术股份有限公司 2025 年第三季度报告 证券代码：300406 证券简称：九强生物 公告编号：2025-095 债券代码：123150 债券简称：九强转债 2025 年第三季度报告 北京九强生物技术股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 北京九强生物技术股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（ ...

Financial Performance - In Q3 2025, the company's operating revenue reached ¥27,584,043,546.48, representing a significant year-on-year increase of 139.04%[5] - The net profit attributable to shareholders for Q3 2025 was ¥1,256,306,602.29, reflecting a year-on-year growth of 169.53%[6] - Basic earnings per share for Q3 2025 were ¥0.47, which is a 176.47% increase compared to the same period last year[6] - For the first nine months of 2025, the total operating revenue was ¥48,286,172,796.13, up 6.19% from the previous year[5] - Total operating revenue for the current period reached ¥48.29 billion, an increase of 6.0% from ¥45.47 billion in the previous period[46] - Net profit for the current period was ¥2.17 billion, a decrease of 36.0% compared to ¥3.40 billion in the previous period[46] - The net profit attributable to shareholders of the parent company was ¥2.17 billion, down 35.1% from ¥3.35 billion in the previous period[47] - Basic and diluted earnings per share for the current period were both ¥0.81, compared to ¥1.25 in the previous period[47] Cash Flow and Liquidity - The company reported a net cash flow from operating activities of ¥4,031,518,199.04, a 78.13% increase compared to the same period last year[5] - The net cash flow from operating activities was -4,031,518,199.04, compared to -18,436,847,981.45 in the previous period, indicating an improvement[50] - Total cash inflow from operating activities amounted to 43,654,193,124.83, while cash outflow was 47,685,711,323.87, resulting in a net cash outflow of -4,031,518,199.04[50] - Cash inflow from investment activities was 45,829,220.34, while cash outflow was 1,095,324,536.25, leading to a net cash outflow of -1,049,495,315.91[50] - Cash inflow from financing activities totaled 3,172,329,334.95, with cash outflow of 4,565,158,587.44, resulting in a net cash outflow of -1,392,829,252.49[51] - The total cash and cash equivalents at the end of the period were 20,465,194,212.48, down from 26,940,471,046.71 at the beginning of the period[51] Assets and Liabilities - The total assets at the end of the reporting period were ¥117,749,854,177.72, marking a 9.12% increase from the end of the previous year[5] - Total liabilities increased significantly, with accounts payable rising by 34.53% compared to the end of last year, indicating outstanding payments to suppliers[20] - Total liabilities increased to ¥95.54 billion, up 10.0% from ¥86.24 billion in the previous period[46] - The company’s total non-current liabilities decreased to ¥8.50 billion from ¥10.22 billion, a decline of 16.8%[46] - The total cash and cash equivalents at the end of the period were 20,465,194,212.48, down from 26,940,471,046.71 at the beginning of the period[51] Shareholder Information - The number of common shareholders at the end of the reporting period was 72,211[39] - The largest shareholder, China Aviation Industry Group, holds 78.66% of the shares, totaling approximately 2.10 billion shares[39] Expenses and Investments - Research and development expenses decreased by 37.76% year-on-year, mainly due to reduced self-funded project investments[29] - The company reported a decrease in research and development expenses to ¥336.28 million from ¥540.32 million, a reduction of 37.7%[46] - The company paid 5,056,374,447.51 in employee compensation, slightly up from 4,986,185,227.78 in the previous period[50] - The company absorbed investments totaling 30,000,000.00 from minority shareholders[51] Other Financial Metrics - Non-recurring gains and losses for the reporting period included government subsidies amounting to ¥17,988,577.94[8] - The company did not identify any other non-recurring gains or losses beyond those reported[10] - Accounts receivable decreased by 91.57% compared to the end of last year, mainly due to the collection of receivables during the period[11] - Prepayments increased by 121.99% compared to the end of last year, primarily due to increased advance payments to suppliers[14] - Contract assets increased by 126.62% compared to the end of last year, mainly because some sales have not yet reached the payment stage[15] - Total profit decreased by 33.42% year-on-year, primarily due to changes in the product sales structure[32] - Net profit decreased by 35.96% year-on-year, attributed to the reduction in total profit[33] - Financial expenses decreased by 87.41% year-on-year, mainly due to a reduction in interest income[30] - Other current assets increased by 451.02% compared to the end of last year, primarily due to an increase in deductible VAT input tax[16]

Revenue and Profitability - Revenue for Q3 2025 reached ¥130,144,941.51, an increase of 35.61% compared to the same period last year[5] - Net loss attributable to shareholders was ¥3,349,641.30, a decline of 125.96% year-over-year[5] - Net profit attributable to shareholders after deducting non-recurring gains and losses was ¥3,539,451.62, down 137.48% from the previous year[5] - The basic earnings per share for Q3 2025 was -¥0.0058, a decrease of 126.01% compared to the same period last year[5] - The net profit for the current period was a loss of ¥2,953,410.30, compared to a net profit of ¥24,969,730.91 in the previous period, indicating a significant decline[19] - The company reported a basic and diluted earnings per share of -¥0.0024, down from ¥0.0426 in the previous period[19] Assets and Liabilities - Total assets as of the end of Q3 2025 amounted to ¥1,200,027,977.61, reflecting a 2.43% increase from the end of the previous year[5] - Total liabilities rose to ¥435,961,230.83, compared to ¥418,326,816.93, marking an increase of 4.03%[17] - The company's total assets increased to ¥1,200,027,977.61 from ¥1,171,609,274.01, representing a growth of 2.93%[17] - The total equity attributable to shareholders increased to ¥751,555,190.03 from ¥744,204,586.47, a growth of 0.15%[17] Cash Flow - Operating cash flow for the first nine months of 2025 decreased by 53.21% to ¥10,907,452.61 compared to ¥23,309,896.33 in the same period of 2024, primarily due to increased procurement expenses[11] - Cash flow from operating activities was ¥296,067,202.72, compared to ¥245,970,827.41 in the previous period, reflecting an increase of 20.25%[20] - The net cash flow from operating activities was $10,907,452.61, a decrease of 53% compared to $23,309,896.33 in the previous period[21] - The total cash and cash equivalents at the end of the period were $123,794,039.16, down from $196,616,655.88 at the beginning of the period[22] - The company’s net increase in cash and cash equivalents was -$1,834,904.98, compared to -$110,317,125.17 in the previous period[21] Investment Activities - Cash inflow from investment activities increased by 41.24% to ¥681,062,400.70, up from ¥482,215,241.38 year-on-year[11] - Cash received from other investment activities rose by 41.05% to ¥670,000,000.00, compared to ¥475,000,000.00 in the previous year[11] - Cash received from investment activities netted ¥16,557,501.10, a significant increase of 115.93% from a negative cash flow of ¥103,957,526.59 in the previous year[11] - The company received cash from investment amounting to ¥5,000,000.00, a 233.33% increase from ¥1,500,000.00 in the previous period[11] - Cash inflow from investment activities totaled $681,062,400.70, significantly up from $482,215,241.38, marking an increase of approximately 41.3%[21] - Cash outflow for investment activities was $664,504,899.60, compared to $586,172,767.97 in the previous period, reflecting a rise of approximately 13.3%[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 89,335, with no preferred shareholders having restored voting rights[13] - The largest shareholder, Lin Xuxi, holds 14.95% of the shares, totaling 86,669,683 shares[13] Expenses - Management expenses rose to ¥32,928,477.63, an increase of 29.38% due to higher payment costs[9] - Research and development expenses for the current period were ¥9,163,115.53, a decrease from ¥10,922,461.67 in the previous period, indicating a reduction of 16.06%[18] - The company’s other income decreased to ¥782,805.34 from ¥4,153,141.98, a decline of 81.14%[18] Financing Activities - Cash flow from financing activities decreased by 61.99% to ¥30,981,448.00, down from ¥81,500,000.00 in the same period last year[11] - The company paid $60,000,000.00 in debt repayment, down from $110,000,000.00 in the previous period[21] - The cash inflow from financing activities was $30,981,448.00, a decrease from $81,500,000.00 in the previous period[21] - The net cash flow from financing activities was -$29,459,740.87, slightly improved from -$29,684,886.07 in the previous period[21] Other Financial Metrics - Total operating revenue for the current period reached ¥301,289,080.80, an increase of 20.97% compared to ¥248,872,976.99 in the previous period[18] - Total operating costs amounted to ¥307,293,836.23, up from ¥249,344,057.87, reflecting a rise of 23.19%[18] - The company reported a total non-recurring gains and losses of ¥189,810.32 for the current period[6] - Cash paid for the purchase of fixed assets and other long-term assets increased by 102.40% to ¥14,504,899.60 compared to ¥7,166,339.97 last year[11] - The company reported a cash flow impact from exchange rate changes of $159,882.18, compared to $15,391.16 previously[21]

Revenue and Profit - Q3 2025 revenue reached ¥12.66 billion, an increase of 3.29% year-over-year, while year-to-date revenue totaled ¥37.49 billion, up 5.59%[3] - Net profit attributable to shareholders decreased by 45.21% to ¥201.21 million in Q3 2025, and year-to-date net profit fell by 48.15% to ¥729.99 million[3] - Basic earnings per share for Q3 2025 was ¥0.0696, down 45.20% compared to the same period last year, with diluted earnings per share at ¥0.0696, a decrease of 43.73%[3] - Total operating revenue for the current period reached ¥37,492,667,728.57, an increase of 5.57% compared to ¥35,508,924,913.89 in the previous period[23] - Net profit for the current period was ¥740,680,978.40, a decrease of 48.36% from ¥1,434,785,106.41 in the previous period[24] - Earnings per share (EPS) decreased to 0.2524 from 0.4866, indicating a decline of 48.2%[25] - The net profit for the current period was a loss of CNY 60,828,437.54, compared to a net profit of CNY 107,250,935.18 in the previous period, indicating a significant decline[32] - The total profit (loss) for the current period was CNY -73,942,676.64, down from CNY 170,965,488.67 in the previous period[32] Assets and Liabilities - Total assets as of September 30, 2025, were ¥36.46 billion, a decline of 7.27% from the end of the previous year[3] - Total assets decreased to ¥36,460,363,485.35 from ¥39,317,902,525.22, a reduction of 7.4%[22] - Total liabilities decreased to ¥15,661,466,121.07 from ¥18,745,810,383.74, a decline of 16.5%[22] - The company’s total non-current liabilities increased to ¥7,116,074,139.74 from ¥6,358,937,692.50, an increase of 11.94%[22] - Total assets increased to ¥30,812,559,544.70 from ¥29,546,645,667.12, reflecting a growth of 4.3%[31] - Total liabilities rose to ¥8,721,060,810.58, up from ¥6,837,682,903.91, indicating an increase of 27.6%[31] - Owner's equity decreased to ¥22,091,498,734.12 from ¥22,708,962,763.21, a decline of 2.7%[31] Cash Flow - Net cash flow from operating activities for the first nine months of 2025 was ¥1.67 billion, down 48.11% year-over-year, attributed to increased cash payments for goods and services[13] - Operating cash flow for the current period was ¥1,667,470,197.66, a decrease of 48.0% compared to ¥3,213,401,822.58 in the previous period[26] - Cash inflow from operating activities totaled ¥40,970,522,251.65, compared to ¥39,343,138,836.47 in the previous period, marking a growth of 4.1%[26] - Cash outflow from operating activities was ¥39,303,052,053.99, an increase of 5.9% from ¥36,129,737,013.89 in the previous period[26] - The company reported a net cash flow from investment activities of ¥130,781,002.36, a significant improvement from -¥2,127,602,279.89 in the previous period[27] - Net cash flow from financing activities was -¥3,105,349,291.89, worsening from -¥629,309,998.76 in the previous period[27] Investments and Expenses - Investment income dropped by 79.20% to ¥75.42 million for the first nine months of 2025, primarily due to reduced equity disposal gains[11] - Research and development expenses were ¥210,659,343.61, slightly down from ¥212,346,700.49, indicating a decrease of 0.79%[24] - The company incurred sales expenses of CNY 27,515.72 in the current period, with management expenses amounting to CNY 25,792,637.92, down from CNY 40,753,075.84 in the previous period[32] - The company reported investment income of CNY 764,720.85, a significant decrease from CNY 288,358,958.39 in the previous period[32] Shareholder Information - The company reported a total of 1,520,175,088 shares held by Shanghai Luojiesi Investment Management Co., Ltd., representing 52.43% of the total shares[16] - The company issued the third tranche of medium-term notes amounting to 1 billion RMB on July 16-17, 2025, with funds received on July 18, 2025[17] - The company completed the repayment of a 500 million USD bond issued on August 19, 2020, with a maturity date of August 19, 2025, at a coupon rate of 2.25%[18] - The stock option incentive plan allowed 15,946,000 options to be exercised, representing 0.55% of the total share capital, with an exercise price of 9.36 RMB per share[18]

Financial Performance - The company's revenue for Q3 2025 was CNY 130,621,007.30, representing an increase of 11.25% compared to the same period last year[5] - The net profit attributable to shareholders for Q3 2025 was CNY 9,135,775.75, a decrease of 18.76% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 3,606,910.97, down 61.76% from the previous year[5] - Basic and diluted earnings per share for Q3 2025 were CNY 0.1013, a decline of 39.04% compared to the same period last year[5] - Total operating revenue for the current period was ¥402,914,193.23, a decrease of 2.87% from ¥414,106,849.37 in the previous period[20] - Net profit for the current period was ¥33,785,095.34, down 39.8% from ¥56,102,946.58 in the previous period[21] - Earnings per share (EPS) decreased to ¥0.3745 from ¥0.8292, reflecting a decline of 54.8%[21] Assets and Liabilities - Total assets at the end of Q3 2025 were CNY 1,171,747,384.34, reflecting a slight increase of 0.22% from the end of the previous year[5] - The company reported a total current assets of ¥785,116,612.55 as of September 30, 2025, slightly down from ¥787,923,132.95 at the beginning of the period, indicating a decrease of approximately 0.23%[16] - The total non-current assets amounted to ¥377,262,391.76, with fixed assets showing a substantial increase from ¥60,714,263.28 to ¥227,001,612.71, marking an increase of about 273.5%[16] - Total liabilities decreased to ¥227,810,195.33 from ¥237,759,558.51, a reduction of 4.2%[18] - The company’s total restricted shares increased to 57,061,550, with a significant portion set to be released in the coming years, impacting shareholder structure[13] Cash Flow - The company reported a cash flow from operating activities of CNY 8,171,680.78, which decreased by 6.68% year-to-date[5] - Operating cash inflow for the current period was CNY 348,499,978.61, an increase of 2.9% from CNY 340,976,176.28 in the previous period[23] - Net cash flow from operating activities decreased to CNY 8,171,680.78 from CNY 8,756,516.33, reflecting a decline of 6.7%[23] - Cash inflow from investment activities surged to CNY 403,347,783.50, compared to CNY 61,617,283.93 in the previous period, marking a significant increase[23] - Net cash flow from investment activities was negative at CNY -187,707,078.00, worsening from CNY -66,411,601.76[23] - Total cash inflow from financing activities was CNY 89,449,430.55, down from CNY 303,580,684.70[24] - Net cash flow from financing activities decreased significantly to CNY 20,585,243.39 from CNY 294,765,841.45[24] - The ending cash and cash equivalents balance was CNY 157,369,518.95, down from CNY 365,031,119.08[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 12,043[9] - The company’s long-term equity investments stood at ¥1,500,000.00, with no prior balance reported, indicating a new investment strategy[16] Strategic Changes - The company plans to change its registered address, which was approved by the board and shareholders, indicating a strategic move to align with operational needs[14] - The company has completed the necessary business registration changes as of September 15, 2025, following the board's resolutions[14] Expenses - The decline in net profit was attributed to increased expenses from new projects and a decrease in sales gross margin[10] - Total operating costs increased to ¥367,728,277.59, up 4.4% from ¥350,651,217.90 in the previous period[20] - Research and development expenses rose to ¥23,360,946.64, an increase of 13.2% compared to ¥20,641,921.02 in the previous period[20] - The company reported a credit impairment loss of ¥5,617,048.55, worsening from ¥4,343,293.03 in the previous period[20]

Financial Performance - The company's revenue for Q3 2025 was ¥145,101,432.38, representing a decrease of 2.35% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥100,571,144.00, a significant decline of 1,050.59% year-on-year[5]. - Total operating revenue decreased to ¥479,272,795.98 from ¥555,153,898.83, representing a decline of approximately 13.7% year-over-year[16]. - Net profit attributable to shareholders of the parent company was a loss of ¥96,287,817.86, compared to a profit of ¥15,870,573.82 in the previous period[18]. - The basic and diluted earnings per share were both reported at -0.52, compared to 0.1 in the previous period[18]. - The company's basic and diluted earnings per share were both -¥0.54, reflecting a decrease of 800.00% year-on-year[5]. - The weighted average return on equity was -7.87%, a decline of 948.80% compared to the same period last year[5]. Cash Flow - The net cash flow from operating activities was -¥40,420,647.49, an increase of 82.77% compared to the previous year[8]. - The net cash flow from operating activities was a negative ¥40,420,647.49, an improvement from a negative ¥234,556,832.49 in the previous period[19]. - The net cash inflow from investment activities was $85.51 million, a significant improvement compared to a net outflow of $217.14 million in the previous period[20]. - Cash inflow from financing activities totaled $312.37 million, down from $425.19 million in the prior period[20]. - The net cash outflow from financing activities was $126.99 million, contrasting with a net inflow of $50.43 million previously[20]. - The ending cash and cash equivalents balance was $144.68 million, a decrease from $226.58 million at the beginning of the period[20]. - The company reported a significant increase in cash received from sales, totaling ¥606,564,125.07, compared to ¥440,365,821.21 in the previous period, an increase of approximately 37.7%[19]. Assets and Liabilities - Total assets at the end of Q3 2025 were ¥3,281,154,611.47, down 7.65% from the end of the previous year[5]. - Total current assets decreased from 3,275,191,649.39 CNY to 2,985,065,838.56 CNY, a reduction of approximately 8.83%[12]. - Total liabilities decreased to ¥2,032,634,297.03 from ¥2,206,875,298.50, a reduction of about 7.9%[14]. - The total equity attributable to shareholders of the parent company decreased to ¥1,221,289,645.59 from ¥1,327,762,617.10, a decline of approximately 8%[14]. - Total current liabilities decreased from 1,881,562,867.70 CNY to 1,696,146,276.19 CNY, a reduction of about 9.83%[13]. - Short-term borrowings decreased from 435,131,211.86 CNY to 369,941,867.04 CNY, a decline of approximately 14.9%[13]. - Long-term equity investments decreased from 43,700,118.91 CNY to 35,538,715.89 CNY, a reduction of about 18.6%[13]. - The company has a total of 1,429,053,342.32 CNY in contract assets, an increase from 1,342,232,547.31 CNY[12]. - The company reported a total of 327,544,495.56 CNY in bonds payable, an increase from 317,360,761.01 CNY[13]. Expenses - The company reported a significant increase in credit impairment losses, amounting to -¥118,699,248.99, up 68.97% year-on-year[8]. - Investment income decreased by 68.97%, totaling -¥438,548.68 for the period[8]. - Research and development expenses decreased to ¥14,647,686.84 from ¥19,529,759.10, a decline of approximately 25% year-over-year[16]. - Total operating costs decreased to ¥454,675,946.29 from ¥500,716,078.45, a reduction of about 9.2% year-over-year[16]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 10,825[10]. - The largest shareholder, Wang Yisen, holds 20.78% of shares, totaling 38,220,000 shares[10]. Other Information - The company did not undergo an audit for the third quarter financial report[21]. - The company plans to implement new accounting standards starting in 2025[21].